• About
  • Subscribe
  • Advertise
  • Contact
Thursday, July 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Systematic barriers letting down older Australians, MDFA report

by Staff Writer
January 3, 2017
in International
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

Currently, only 10-15% of people with low vision access services, which the report noted was in part a result of inadequate distribution and a lack of coordination amongst low vision services.It also listed educational shortfalls and poor collaboration between different service providers as exacerbating issues.The report, “Low Vision, quality of life and independence: A review of the evidence on aids and technologies”, which is based on collective data from Australian government and private institutions, argued aside from systic barriers, individual inaction and educational shortfalls were other contributing factors.Systic barriersProduced in collaboration with The George Institute for Global Health, the report also stated that Australia’s low vision sector has predominantly been the realm of NGOs.This has led to limited public and private support, with low vision services that often operate in isolation to clinical services.{{quote-A:R-W:450-I:2-Q: Low vision aids ranging from a simple magnifier or specialised lighting, through to adaptive technology, can transform the lives of people with sight loss, helping th to live to fulfill, independent lives. -WHO:Ms Julie Heraghty, CEO of MDFA}}A further consequence is a service delivery syst that varies by state and individual organisation, leading to some jurisdictions experiencing an overall shortage of services.It also contends that the current model of low vision care is fragmented, lacks collaboration, and underutilises the potential of primary and secondary optometry to relieve already stretched ophthalmic services.“Few private optometrists provide low vision services and the number of patients seen by these optometrists is small,” the report says.“Also GPs lacked awareness of the services provided by low vision organisations and the value of those services for patients.“Factors such as this may be attributed to the tendency of low vision NGOs to focus attention on their blind clientele, rather than generate a broader awareness of the services they provide.”Other systic barriers listed include a lack of confidence among optometrists to provide low vision support services, and inadequate runeration for the time needed to conduct assessments and prescribe low vision aids.Individual barriersAccording to the authors, patients often don’t perceive thselves as having low vision, even in cases where moderate or severe VI is present.This self denial may result in avoidant coping behaviour, which can also be linked to a patient’s belief that their vision probls are out of their control or unsolvable.These perceptions were identified as a major barrier to low vision service uptake, and were backed up by a 2011 study that found 37% of patients declined a referral to a low vision service, based on the believe that it was not needed or would not help.Meanwhile, patients with mobility probls – thought to be 74% of those requiring assistance – said distance from services and the use of public transport or taxis were other obstacles.Cost, education, contributing factors{{image3-a:r-w:400}}A number of programs exist that are designed to improve living conditions for those with vision probls and blindness, however, prohibitive costs and a lack of awareness has led to th being underutilised, especially by the elderly.The authors attributed this to a poor understanding of both the term and definition of “low vision”, as patients could perceive thselves as being either visually impaired or blind, rather than somewhere in between.Meanwhile, another study quoted in the report found that 34% of failed referrals spoke a language other than English, suggesting that language and cultural appropriateness may also present a barrier to access.Possible solutionsMs Julie Heraghty, CEO of MDFA, said that “low vision aids ranging from a simple magnifier or specialised lighting, through to adaptive technology, can transform the lives of people with sight loss, helping th to live to fulfill, independent lives. “Currently, the vast majority of people in Australia with sight loss have great difficulty affording or accessing these aids. This needs to change,” Heraghty said.To address the situation the MDFA recommends increased investment in research and development of vision-related technologies; establish a nationally-funded program to enhance existing government mechanisms and subsidy in private health insurance coverage.Heraghty pointed out that, “while successive governments are to be commended for subsidising registered sight-saving drugs to avoid vision loss, unfortunately, many older Australians who are vision impaired or blind, are repeatedly missing out on the support they most need – low vision aids and technologies”.The MDFA estimates the initial cost of a federally funded program to be around $30 million per year with a suggested annual allowance of between $667 and $2,400 per person per annum, depending on vision assessment.Heraghty added that these recommendations are “financially achievable” and that the MDFA will urge the Minister for Health to also focus on many older Australians who are not covered by the National Disability Insurance Sche (NDIS) to entitle th with the same level of support.

Related Posts

The capsule collection draws from Carrera’s historic colours – black, white and red. Image: Carrera.

Carrera celebrates milestone with limited-edition collection

by Rob Mitchell
July 14, 2026

To celebrate its 70th anniversary, Carrera has announced the introduction of an exclusive Made in Italy limited-edition capsule collection that...

Red and bulging eyes are symptoms of thyroid eye disease. Image: Antonio/stock.adbe.com.

FDA approves first treatment of thyroid eye disease

by Rob Mitchell
July 1, 2026

The FDA has announced the approval of the first treatment for thyroid eye disease (TED) with labelling that includes data...

Dr Emmanuel Ho and his team of researchers have developed a low-cost, first-line screening tool. Image: University of Waterloo.

App screens eye to detect changes in cognitive health

by Rob Mitchell
June 30, 2026

Dr Emmanuel Ho, professor at the University of Waterloo School of Pharmacy in Canada, has received support through the Centre...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited